Prevalence of Metabolic Syndrome in Atahualpa

Metabolic Syndrome Clinical Trial

Official title:

Evaluation of the Prevalence of Metabolic Syndrome in Atahualpa Residents Aged 40 Years or More.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01770054
• Other study ID #: TAP 001-2013
• Secondary ID: 001-2013-01
• Status: Completed
• Phase: N/A
• First received: January 15, 2013
• Last updated: March 7, 2013
• Start date: January 2013
• Est. completion date: March 2013

Study information

• Verified date: March 2013
• Source: Hospital Clínica Kennedy
• Contact: n/a
• Is FDA regulated: No
• Health authority: Ecuador: Ethical Committee
• Study type: Observational [Patient Registry]

Clinical Trial Summary

A recent epidemiologic survey demonstrated a high prevalence of type 2 diabetes mellitus in Atahualpa residents. Now, the investigators attempt to evaluate the prevalence of the metabolic syndrome in adults aged 40 years or more living in this rural village of coastal Ecuador.

Description:

Several studies have shown that the occurrence of the metabolic syndrome is a risk factor for the development of cerebrovascular and ischemic heart disease. To evaluate the prevalence of the metabolic syndrome, we will invite all Atahualpa residents aged 40 years or more to participate in this study. For the purposes of this study we will obtain the waist circumference of all individuals, will measure their blood pressure using a standard protocol, and will take a blood sample to determine fasting glucose levels, HDL cholesterol levels, triglyceride levels, and plasma insulin levels.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 517
• Est. completion date: March 2013
• Est. primary completion date: March 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 40 Years and older

Eligibility

Inclusion Criteria:

• Atahualpa resident aged 40 years or more

Exclusion Criteria:

• non-consenting persons

Study Design

Observational Model: Ecologic or Community, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Metabolic Syndrome
• Metabolic Syndrome X
• Syndrome

Intervention

Other:
• obtention of a blood sample
a blood sample will be obtained to measure glucose, HDL cholesterol, triglycerides, and for genetic testing

Locations

Country	Name	City	State
Ecuador	Center of Health	Atahualpa	Santa Elena

Sponsors (1)

Lead Sponsor	Collaborator
Hospital Clínica Kennedy

Country where clinical trial is conducted

Ecuador, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	determination of the prevalence of hyperinsulinemia	plasma insulin levels will be determined	5 months	No
Primary	Prevalence of metabolic syndrome	determination of the metabolic syndrome in subjects aged 40 years or more	5 months	No
Secondary	Genetic testing	Blood will be taken to evaluate the ADN pattern of this population, to compare with other Amerindian populations with a proven high prevalence of diabetes mellitus and metabolic syndrome	5 months	No